\n\nMethods: Cross-sectional study using data available from 6,139 Spanish children between 2-15 years old, included in the National Health Survey. Parents or guardians reported weight and height to estimate obesity prevalence according to the International Obesity Task Force cut-offs for body mass index.\n\nResults: Obesity prevalence was 10,3% and overweight prevalence was 18,8%. Obesity was more prevalent in children from 4-5 years age (18,3%) and overweight in the 8-9 years stratus (25,5%). Overweight was more frequent in boys than girls

(19,8% versus 17,8%; p = 0,04). Canary Islands, Ceuta and Melilla, Valencia and Andalusia were the Autonomous Communities with higher obesity prevalence in contrast with the Basque Country, Galicia and Madrid which showed the lowest prevalence. This distribution generates a north to south gradient

in obesity prevalence. Both, obesity and MAPK Inhibitor Library ic50 overweight showed an inverse association with socioeconomic position (p < 0,05).\n\nConclusion: Childhood obesity rates in Spain accounts from ones of the highest in Europe, with a strong geographic and socioeconomic gradient. Priority should be given to effective interventions that can reach the most vulnerable groups as identified in this study, like restrictions on TV food advertising and tax reliefs to promote healthy eating.”
“Small ubiquitin-like modifier 1 (SUMO1) and environmental factors have been shown to be associated with nonsyndromic cleft lip with or without BIX 01294 concentration cleft palate (NSCL/P) in several populations. This study aimed at confirming the contribution of SUMO1 gene and environmental factors to nonsyndromic orofacial clefts risk in western Han Chinese. Four single-nucleotide polymorphisms were investigated in 212 case trios in western China using conditional

logistic regression models and the transmission disequilibrium test under a case-parent trio design. Strong evidence of linkage and linkage disequilibrium was found between these markers and the disease in both single-nucleotide polymorphism analysis (T allele at rs6761234 [p = 0.0005, odds ratio [OR] = 1.82, 95% confidence interval [CI]: www.selleckchem.com/products/sbe-b-cd.html 1.30-2.57) and C allele at rs12470401 (p < 0.0001, OR = 2.82, 95% CI: 1.90-4.19)] and sliding window haplotype analysis (T-T-T for rs6761234-rs12470401-rs7599810 [p = 0.018], C-C-G for rs12470401-rs7599810-rs6435133 [0.0033], C-T-T-T for rs6761234-rs12470401-rs7599810-rs6435133 [p = 0.018] among others). Interactions between mothers’ passive smoking during the first trimester and C/C genotype of rs12470401 showed statistical significance (OR(0) = 2.53 and OR(1) = 8.83). Risk factors identified in this study may provide a better understanding of the etiological role of SUMO1 gene in NSCL/P incidence.